Publications by authors named "Jingga Morry"

Claim this Profile
R
Removal of a gadolinium based contrast agent by a novel sorbent hemoperfusion in a chronic kidney disease (CKD) rodent model.
Worapol Ngamcherdtrakul, Jingga Morry, Thanapon Sangvanich, Moataz Reda, Daniel S Bejan

Sci Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles.
Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee

Redox Biol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu, Moataz Reda, David J Castro

Mol Cancer Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.
Worapol Ngamcherdtrakul, David J Castro, Shenda Gu, Jingga Morry, Moataz Reda

Cancer Treat Rev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic siRNA for drug-resistant HER2-positive breast cancer.
Shenda Gu, Zhi Hu, Worapol Ngamcherdtrakul, David J Castro, Jingga Morry

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis.
Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu, Shaun M Goodyear, David J Castro

Biomaterials· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
Rong Qi, Istvan Majoros, Asish C Misra, Alisa E Koch, Phil Campbell, Jingga Morry

J Biomed Nanotechnol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted SiRNA Delivery to HER2+ Breast Cancer.
Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu, David J Castro, Shaun M Goodyear

Adv Funct Mater· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel oral detoxification of mercury, cadmium, and lead with thiol-modified nanoporous silica.
Thanapon Sangvanich, Jingga Morry, Cade Fox, Worapol Ngamcherdtrakul, Shaun Goodyear

ACS Appl Mater Interfaces· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoporous sorbent material as an oral phosphate binder and for aqueous phosphate, chromate, and arsenate removal.
Thanapon Sangvanich, Worapol Ngamcherdtrakul, Richard Lee, Jingga Morry, David Castro

J Nanomed Nanotechnol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OT-II TCR transgenic mice fail to produce anti-ovalbumin antibodies upon vaccination.
Shelly Leung, Douglas Smith, Andrzej Myc, Jingga Morry, James R Baker

Cell Immunol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis